Understand the source comparison
Kisspeptin FAQ: Comparison of Research Peptides for Reproductive Axis Modulation
Researchers often evaluate kisspeptin alongside other peptides that interact with the HPG axis. The table below compares kisspeptin-10, gonadorelin (GnRH), and hCG based on mechanism, receptor target, half-life, and experimental use case. Kisspeptin-10 Stimula
No winner is assigned.
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- Researchers often evaluate kisspeptin alongside other peptides that interact with the HPG axis. The table below compares kisspeptin-10, gonadorelin (GnRH), and hCG based on mechanism, receptor target, half-life, and experimental use case.
- Kisspeptin-10
- Stimulates endogenous GnRH neurons to release GnRH in pulsatile bursts
- KISS1R (GPR54) on hypothalamic GnRH neurons
- 27–33 minutes (plasma)
- HPG axis restoration studies, puberty onset modeling, reproductive neuroendocrinology
- Upstream control. Restores natural pulsatility without suppressing endogenous production
- Gonadorelin (GnRH)
- Directly stimulates pituitary gonadotrophs to release LH and FSH
- GnRH receptor (GnRHR) on anterior pituitary gonadotrophs
- 2–4 minutes (plasma)
- Ovulation induction, pituitary function testing, fertility research
- Mid-axis stimulation. Bypasses hypothalamus but requires pulsatile dosing to avoid desensitization
- hCG (human chorionic gonadotropin)
- Mimics LH, directly stimulates gonadal Leydig/theca cells to produce testosterone/progesterone
- LH receptor (LHR) on testicular Leydig cells and ovarian theca cells
- 24–36 hours (plasma)
- Direct gonadal stimulation, luteal phase support, testicular function models
- Downstream hormone. Bypasses entire HPG axis, suppresses endogenous LH over time
- Clomiphene citrate (comparator)
- Blocks estrogen negative feedback at hypothalamus/pituitary, indirectly increasing GnRH/LH/FSH
- Estrogen receptor (antagonist at hypothalamus, mixed agonist/antagonist at other tissues)
- 5–7 days (plasma)
- Ovulation induction, hypogonadism treatment models, SERM mechanism studies
- Indirect modulation. Works by removing brake on GnRH, not by stimulating release